Literature DB >> 25556072

Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.

Jie Li1, Enze Jiang2, Xinxing Wang1, Anna Junjie Shangguan3, Luo Zhang4, Zhenghong Yu5.   

Abstract

Tumor dormancy is one of the stages in tumor development without clinical symptoms. Tumor dormant cells may appear in early stages of tumor development, as well as in micrometastasis and minimal residual disease. The mechanism for the switch of dormant cells between quiescent and proliferative stages is still largely unknown. Potential mechanisms that may account for the transition between dormant tumor cells and proliferative cells include angiogenesis, immune response, cellular factors, and signaling pathways. The clinical and therapeutic importance of dormant cells requires further studies to provide therapeutic strategies for inhibition of metastasis and tumor recurrence.

Entities:  

Keywords:  Cell cycle; Dormant cells; Metastasis; Tumor; Tumor recurrence

Mesh:

Year:  2015        PMID: 25556072     DOI: 10.1007/s12013-014-0477-4

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  9 in total

Review 1.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

2.  Simulating the Selection of Resistant Cells with Bystander Killing and Antibody Coadministration in Heterogeneous Human Epidermal Growth Factor Receptor 2-Positive Tumors.

Authors:  Bruna Menezes; Jennifer J Linderman; Greg M Thurber
Journal:  Drug Metab Dispos       Date:  2021-10-14       Impact factor: 3.922

3.  In Surgical Colon Cancer Patients Extended-Duration Thromboprophylaxis (30 days) with the Highest Dose of Tinzaparin (4,500 IU s.c./q.d.) Normalizes the Postoperative VEGF Levels.

Authors:  Michail Mitsis; Panagiotis Koliou; Christina Bali; Evangelia Ntounousi; Vasileios Tatsis; Vasileios Nousias; Georgios D Lianos; Georgios Vartholomatos; Dimitrios Nastos
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

4.  Late-Onset Metastatic Renal Cell Carcinoma to the Thyroid Gland: An Unusual Airway Emergency.

Authors:  Soraya Abdul-Hadi; Francis Daniel Beauchamp; Jorge Cheverez-Ocasio; Jeamarie Pascual-Marrero; Juan C Portela-Arraiza; Maria Correa-Rivas
Journal:  Am J Case Rep       Date:  2022-02-15

5.  Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy.

Authors:  Xing Wang; Jiandi Yu; Junfeng Yan; Kun Peng; Haiyong Zhou
Journal:  BMC Urol       Date:  2022-03-19       Impact factor: 2.264

6.  Fractionated irradiation of MCF7 breast cancer cells rewires a gene regulatory circuit towards a treatment-resistant stemness phenotype.

Authors:  Auchi Inalegwu; Bart Cuypers; Jürgen Claesen; Ann Janssen; Amelie Coolkens; Sarah Baatout; Kris Laukens; Winnok H De Vos; Roel Quintens
Journal:  Mol Oncol       Date:  2022-06-15       Impact factor: 7.449

Review 7.  The Role of Cancer Stem Cells in Radiation Resistance.

Authors:  Christoph Reinhold Arnold; Julian Mangesius; Ira-Ida Skvortsova; Ute Ganswindt
Journal:  Front Oncol       Date:  2020-02-20       Impact factor: 6.244

8.  Nucleolar Sequestration: Remodeling Nucleoli Into Amyloid Bodies.

Authors:  Miling Wang; Michael Bokros; Phaedra Rebecca Theodoridis; Stephen Lee
Journal:  Front Genet       Date:  2019-11-21       Impact factor: 4.599

Review 9.  Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.

Authors:  Magdalena Jurczyk; Katarzyna Jelonek; Monika Musiał-Kulik; Artur Beberok; Dorota Wrześniok; Janusz Kasperczyk
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.